openPR Logo
Press release

Chronic Inflammatory Demyelinating Polyneuropathy Market Research Updates and Clinical Trials In 2025

05-15-2025 12:02 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Chronic Inflammatory Demyelinating Polyneuropathy Market

Chronic Inflammatory Demyelinating Polyneuropathy Market

The Chronic inflammatory Demyelinating Polyneuropathy Market size reached US$ 2.02 Billion in 2024 and is expected to reach US$ 5.07 Billion by 2033, growing at a CAGR of 9.7% during the forecast period 2025-2033.

Chronic Inflammatory Demyelinating Polyneuropathy Market, as detailed in the DataM Intelligence report, presents a strategic overview of the industry backed by in-depth data and market trends. The study highlights the performance and positioning of major players, focusing on their offerings, pricing models, financial outcomes, and growth strategies. It serves as a concise yet insightful reference for understanding the current landscape and future direction of the market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/chronic-inflammatory-demyelinating-polyneuropathy-market?kb

Market Overview:

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder causing inflammation of peripheral nerves, leading to progressive weakness and sensory dysfunction. It often requires long-term immunotherapy to manage symptoms and improve quality of life.

List of the Key Players in the Chronic Inflammatory Demyelinating Polyneuropathy Market:

Bio Products Laboratory Ltd, Momenta Pharmaceuticals, Grifols, Baxter, Kedrion S.p.A, Octapharma, Shire, Mitsubishi Tanabe Pharma Corporation,CSL Behring, Teijin Pharma Limited and Pfizer, Inc.

Chronic Inflammatory Demyelinating Polyneuropathy Market Development:

In May 2024, Zai Lab Limited submitted a supplemental Biologics License Application (sBLA) to China's National Medical Products Administration (NMPA) for efgartigimod alfa injection (efgartigimod SC) aimed at treating chronic inflammatory demyelinating polyneuropathy (CIDP).

In June 2024, argenx SE announced that the U.S. Food and Drug Administration (FDA) approved VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for adult CIDP patients. This approval represents a major milestone as VYVGART Hytrulo becomes the first and only neonatal Fc receptor (FcRn) blocker authorized for CIDP treatment.

Additionally, in December 2023, Takeda revealed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had recommended HYQVIA for approval as a maintenance therapy for CIDP patients following stabilization with intravenous immunoglobulin (IVIG).

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/chronic-inflammatory-demyelinating-polyneuropathy-market?kb

Segment Covered in the Chronic Inflammatory Demyelinating Polyneuropathy Market:

By Treatment Type: Immunoglobulin Therapy, Corticosteroids , Immunosuppressants, Physical Therapy, Plasma Exchange

By Route of Administration: Oral, Intravenous

By End User: Hospitals, Speciality Clinics, Research and Academic Institutes

Regional Analysis for Chronic Inflammatory Demyelinating Polyneuropathy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Frequently asked questions:

➠ What are the global sales, production, consumption, import, and export figures for the Chronic Inflammatory Demyelinating Polyneuropathy market?

➠ Who are the key global manufacturers, and how are they performing operationally?

➠ What opportunities and risks do vendors face in the Chronic Inflammatory Demyelinating Polyneuropathy market?

➠ Which product types or end-users show the most growth potential, and what are their market shares?

➠ What factors are driving or limiting growth in the Chronic Inflammatory Demyelinating Polyneuropathy market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us-

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us-

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Inflammatory Demyelinating Polyneuropathy Market Research Updates and Clinical Trials In 2025 here

News-ID: 4018087 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Breast Implants Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Sientra Inc, POLYTECH Health & Aesthetics and Bimini Health Tech
United States Breast Implants Market 2025: Industry Developments, Future Growth, …
The Breast Implants Market is estimated at US$ 1.88 billion in 2024 and is anticipated to reach US$ 3.34 billion by 2033, expanding at a CAGR of 6.6% throughout the forecast period. DataM Intelligence has published a new research report on "Breast Implants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers.
United States Bone Grafts and Substitutes Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Orthofix Medical Inc, DePuy Synthes, Bioventus, Arthrex, Inc
United States Bone Grafts and Substitutes Market 2025: Industry Developments, Fu …
The Bone Grafts and Substitutes Market grew from US$ 3.39 billion to US$ 3.60 billion in 2024 and is projected to reach US$ 6.37 billion by 2033, registering a CAGR of 6.6% during 2025-2033. DataM Intelligence has published a new research report on "Bone Grafts and Substitutes Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top
United States Biotechnology Market 2025: Industry Developments, Future Growth, Share & Industry Insights | AbbVie Inc., AstraZeneca, Gilead Sciences Inc, Bristol-Myers Squibb Company, Sanofi, and Biogen
United States Biotechnology Market 2025: Industry Developments, Future Growth, S …
The Biotechnology Market size increased from US$ 1.53 trillion in 2023 to US$ 1.71 trillion in 2024 and is expected to reach US$ 5.08 trillion by 2033, growing at a CAGR of 13.1% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Biotechnology Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of
United States Bio-Betters Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Amgen Inc, Novo Nordisk A/S, Celltrion, Inc, Altos Biologics Co, Genentech USA
United States Bio-Betters Market 2025: Industry Developments, Future Growth, Sha …
The Bio-Betters Market size grew from US$ 49.87 billion in 2023 to US$ 53.73 billion in 2024 and is projected to reach US$ 110.46 billion by 2033, expanding at a CAGR of 8.5% during the forecast period 2025-2033. DataM Intelligence has published a new research report on "Biobetters Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of

All 5 Releases


More Releases for Chronic

Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030 This latest report researches the industry structure,
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991 This latest report researches the
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them